In support of Rare Disease Day, the EMA has published a question-and-answer document addressing common misunderstandings about the meaning of orphan designation and other aspects pertaining to orphan medicines.
This document explains key concepts in the regulation of medicines for rare diseases such as orphan designation and significant benefit. The Q&A document is available by clicking here.
For more information about orphan designation please click here.
Data Protection: PSNResearch collects, stores and processes data exclusively for the purpose of business operation and according to PSNResearch’s Data Protection Policy. Any personal information submitted to PSNResearch on the contact form is used and stored as an e-mail. PSNResearch will only store your e-mail data for as long as is necessary for the purpose of business operation. When this purpose is no longer relevant the data sets will be deleted as part of PSNResearch’s routine operations.